Baird analyst Cathy Ramsey Schulte raised the firm’s price target on Qiagen (QGEN) to $53 from $48.42 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN: